Review



human cancer survey rt qpcr gene expression panels  (OriGene)


Bioz Verified Symbol OriGene is a verified supplier
Bioz Manufacturer Symbol OriGene manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    OriGene human cancer survey rt qpcr gene expression panels
    Human Cancer Survey Rt Qpcr Gene Expression Panels, supplied by OriGene, used in various techniques. Bioz Stars score: 94/100, based on 39 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/breast+cancer+tumor+array/TissueScan%2C+Breast+Cancer+cDNA+Array+II/pm38476024-258-1-10
    Average 94 stars, based on 39 article reviews
    human cancer survey rt qpcr gene expression panels - by Bioz Stars, 2026-09
    94/100 stars

    Images

    Related Articles

    Real-time Polymerase Chain Reaction:

    Article Title: Ether lipid generating enzyme AGPS alters the balance of structural and signaling lipids to fuel cancer pathogenicity
    Article Snippet: .. Breast cancer tumor array 1 was purchased from Origene, and qPCR was performed on the array using the protocol described above. ..



    Similar Products

    human breast cancer tissue array  (Novus Biologicals)
    93
    Novus Biologicals human breast cancer tissue array
    Human Breast Cancer Tissue Array, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/breast+cancer+tumor+array/Human+Breast+Tissue+MicroArray+(Cancer)/pmc12478062-532-1-9
    Average 93 stars, based on 1 article reviews
    human breast cancer tissue array - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier
    human cancer survey rt qpcr gene expression panels  (OriGene)
    94
    OriGene human cancer survey rt qpcr gene expression panels
    Human Cancer Survey Rt Qpcr Gene Expression Panels, supplied by OriGene, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/breast+cancer+tumor+array/TissueScan%2C+Breast+Cancer+cDNA+Array+II/pm38476024-258-1-10
    Average 94 stars, based on 1 article reviews
    human cancer survey rt qpcr gene expression panels - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier
    miprofile human breast cancer mirna qpcr array  (Genecopoeia)
    92
    Genecopoeia miprofile human breast cancer mirna qpcr array
    Miprofile Human Breast Cancer Mirna Qpcr Array, supplied by Genecopoeia, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/breast+cancer+tumor+array/miProfile+human+cancer+miRNA+qPCR+arrays/pm38163254-281-11-18
    Average 92 stars, based on 1 article reviews
    miprofile human breast cancer mirna qpcr array - by Bioz Stars, 2026-09
    92/100 stars
    		  Buy from Supplier
    paraffin embedded breast cancer tissue arrays  (Novus Biologicals)
    93
    Novus Biologicals paraffin embedded breast cancer tissue arrays
    Paraffin Embedded Breast Cancer Tissue Arrays, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/breast+cancer+tumor+array/Human+Breast+Tissue+MicroArray+(Cancer)/pm36608120-377-0-11
    Average 93 stars, based on 1 article reviews
    paraffin embedded breast cancer tissue arrays - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier
    breast cancer tissue array  (BioChain Institute)
    92
    BioChain Institute breast cancer tissue array
    Breast Cancer Tissue Array, supplied by BioChain Institute, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/breast+cancer+tumor+array/pmc10823288-55-22-29
    Average 92 stars, based on 1 article reviews
    breast cancer tissue array - by Bioz Stars, 2026-09
    92/100 stars
    		  Buy from Supplier
    breast cancer tissue microarray  (BioChain Institute)
    92
    BioChain Institute breast cancer tissue microarray
    Breast Cancer Tissue Microarray, supplied by BioChain Institute, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/breast+cancer+tumor+array/pmc10605610-74-2-7
    Average 92 stars, based on 1 article reviews
    breast cancer tissue microarray - by Bioz Stars, 2026-09
    92/100 stars
    		  Buy from Supplier
    tissuescantm breast cancer cdna arrays  (OriGene)
    91
    OriGene tissuescantm breast cancer cdna arrays
    Figure 1. Expression of IL-13Rα2 in breast cancer tissue. (a) RT-PCR analysis of IL-13Rα2 mRNA expression in <t>cDNA</t> array samples (TissueScan™, Origene) derived from breast cancer (number of samples (n = 60)) and non-malignant (n = 7) tissue. Shown is the fold-change relative to mean expression in non-malignant samples (mean fold-change, cancer versus non-malignant; *** p ≤0.001). (b) Stratification analysis of IL-13Rα2 mRNA expression data comparing TNBC-type (n = 19) versus non-TNBC (n = 41) tumors (mean fold-change, TNBC versus non-TNBC, *** p ≤0.001). (c) Im- munohistochemical analysis of IL-13Rα2 protein expression in breast cancer tissue array samples (US Biomax, BR1009). Shown images (at 40× magnification) are representative examples of specific staining with an anti-IL-13Rα2 antibody (sc-134363) versus a mouse IgG2a isotype control: (left panel), non-malignant tissue; (middle panel) non-TNBC tumor (ER+, stage IIa); (right panel) TNBC tumor (stage IIb). (Right Figure), scoring analysis of anti-IL-13Rα2 reactivity in non-malignant (n = 9), non-TNBC (n = 8), and TNBC (n = 21) tissue array sections (mean score, TNBC versus non-malignant, *** p ≤0.001).
    Tissuescantm Breast Cancer Cdna Arrays, supplied by OriGene, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/breast+cancer+tumor+array/TissueScan%2C+Cancer+Survey+cDNA+Array+96+-+II/pm37345109-66-24-23
    Average 91 stars, based on 1 article reviews
    tissuescantm breast cancer cdna arrays - by Bioz Stars, 2026-09
    91/100 stars
    		  Buy from Supplier

    Image Search Results


    Figure 1. Expression of IL-13Rα2 in breast cancer tissue. (a) RT-PCR analysis of IL-13Rα2 mRNA expression in cDNA array samples (TissueScan™, Origene) derived from breast cancer (number of samples (n = 60)) and non-malignant (n = 7) tissue. Shown is the fold-change relative to mean expression in non-malignant samples (mean fold-change, cancer versus non-malignant; *** p ≤0.001). (b) Stratification analysis of IL-13Rα2 mRNA expression data comparing TNBC-type (n = 19) versus non-TNBC (n = 41) tumors (mean fold-change, TNBC versus non-TNBC, *** p ≤0.001). (c) Im- munohistochemical analysis of IL-13Rα2 protein expression in breast cancer tissue array samples (US Biomax, BR1009). Shown images (at 40× magnification) are representative examples of specific staining with an anti-IL-13Rα2 antibody (sc-134363) versus a mouse IgG2a isotype control: (left panel), non-malignant tissue; (middle panel) non-TNBC tumor (ER+, stage IIa); (right panel) TNBC tumor (stage IIb). (Right Figure), scoring analysis of anti-IL-13Rα2 reactivity in non-malignant (n = 9), non-TNBC (n = 8), and TNBC (n = 21) tissue array sections (mean score, TNBC versus non-malignant, *** p ≤0.001).

    Journal: Cancers

    Article Title: Targeting and Sensitization of Breast Cancer Cells to Killing with a Novel Interleukin-13 Receptor α2-Specific Hybrid Cytolytic Peptide.

    doi: 10.3390/cancers15102772

    Figure Lengend Snippet: Figure 1. Expression of IL-13Rα2 in breast cancer tissue. (a) RT-PCR analysis of IL-13Rα2 mRNA expression in cDNA array samples (TissueScan™, Origene) derived from breast cancer (number of samples (n = 60)) and non-malignant (n = 7) tissue. Shown is the fold-change relative to mean expression in non-malignant samples (mean fold-change, cancer versus non-malignant; *** p ≤0.001). (b) Stratification analysis of IL-13Rα2 mRNA expression data comparing TNBC-type (n = 19) versus non-TNBC (n = 41) tumors (mean fold-change, TNBC versus non-TNBC, *** p ≤0.001). (c) Im- munohistochemical analysis of IL-13Rα2 protein expression in breast cancer tissue array samples (US Biomax, BR1009). Shown images (at 40× magnification) are representative examples of specific staining with an anti-IL-13Rα2 antibody (sc-134363) versus a mouse IgG2a isotype control: (left panel), non-malignant tissue; (middle panel) non-TNBC tumor (ER+, stage IIa); (right panel) TNBC tumor (stage IIb). (Right Figure), scoring analysis of anti-IL-13Rα2 reactivity in non-malignant (n = 9), non-TNBC (n = 8), and TNBC (n = 21) tissue array sections (mean score, TNBC versus non-malignant, *** p ≤0.001).

    Article Snippet: To determine relative IL-13Rα2 mRNA expression in breast cancer tumors representing various stages of the disease, a similar RT-PCR methodology was applied to Origene TissueScanTM Breast Cancer cDNA Arrays (samples from CSRT104, BCRT103, and BCRT104; 60 tumor samples (n = 60) covering various disease stages with non-malignant (n = 7) breast tissue cDNA samples for comparison) [37].

    Techniques: Expressing, Reverse Transcription Polymerase Chain Reaction, Derivative Assay, Staining, Control